Patents by Inventor Marianne Jartved Mathiesen

Marianne Jartved Mathiesen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6716574
    Abstract: A diagnostic method is disclosed which utilizes short C-terminal fragments of Borrelia burgdorferi sensu lato derived protein OspC. The 4 amino-terminal acids Pro-Lys-Pro (SEQ ID NO: 22) are shown to be essential in immune reactivity between sera from patients suffering from early borreliosis and various OspC derivatives and it is shown that in order to be effective as a diagnostic agent, 5 consecutive amino acid residues long homologue of a fragment identical to the 10 C-terminal amino acids of OspC (SEQ DI NO: 1). Also disclosed are vaccines utilizing the short peptides as well as methods for their preparation.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: April 6, 2004
    Assignee: Dako A/S
    Inventors: Marianne Jartved Mathiesen, Michael Theisen, Arne Holm, Søren Østergaard
  • Publication number: 20030138866
    Abstract: A diagnostic method is disclosed which utilizes short C-terminal fragments of Borrelia burgdorferi sensu lato derived protein OspC. The 4 amino-terminal acids Pro-Lys-Pro (SEQ ID NO: 22) are shown to be essential in immune reactivity between sera from patients suffering from early borreliosis and various OspC derivatives and it is shown that in order to be effective as a diagnostic agent, 5 consecutive amino acid residues long homologue of a fragment identical to the 10 C-terminal amino acids of OspC (SEQ DI NO: 1). Also disclosed are vaccines utilizing the short peptides as well as methods for their preparation.
    Type: Application
    Filed: October 10, 2001
    Publication date: July 24, 2003
    Applicant: Statens Serum Institut
    Inventors: Marianne Jartved Mathiesen, Michael Theisen, Arne Holm, Soren Ostergaard